Scrutica
Financial and operational metadata for MedixSafe (geographic revenue exposure, segment breakdowns, capital allocation), connected via industry classification mapping to the broader supply chain. Sourced from FactSet and EDGAR.
Corporate intelligence profile for MedixSafe. Revenue derivation and capital allocation are mapped to evaluate the company's structural role in the broader compute supply chain.
Each hop carries the data source, source URL where available, as-of date, and confidence label inline. Where two sources disagree on a parent, both records are surfaced as alternates; the Investigator does not arbitrate.
Starting entity. The chain walks upward from here through documented parent / subsidiary edges in Scrutica’s ownership substrate.
Per PitchBook (via WRDS)(relation e4490dc8235a…), as of 2025-09-26 (HIGHtier 2): BioConnect (Electronic Equipment and Instruments) is the documented parent.
Per PitchBook (via WRDS), as-of date not recorded (HIGHtier 2): wrds-pb-41078-89 is the documented parent.
Per PitchBook (via WRDS)(relation cadba32bace7…), as of 2025-11-20 (HIGHtier 2): Gentex is the documented parent.
Chain-of-title terminates at Gentex. (GNTX · CIK 355811.) No further parent corporation is documented in Scrutica’s substrate; for publicly-listed corporations, ultimate beneficial ownership distributes across public shareholders. For state-owned entities, the chain reaches sovereign authority.
Documented M&A-shaped events touching this entity (Buyout, Corporate Divestiture, Asset Sale, Joint Venture, Spin-off). Capital raises without ownership transfer are excluded from this list at substrate ingestion.